Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Elite Health Systems (EHSI) Cash & Equivalents (2016 - 2025)

Elite Health Systems' Cash & Equivalents history spans 16 years, with the latest figure at $3.8 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $3.8 million for Q4 2025, down 6.84% from a year ago — trailing twelve months through Dec 2025 was $3.8 million (down 6.84% YoY), and the annual figure for FY2025 was $3.8 million, down 6.84%.
  • Cash & Equivalents for Q4 2025 was $3.8 million at Elite Health Systems, down from $4.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $4.0 million in Q4 2024 to a low of $466000.0 in Q4 2023.
  • The 5-year median for Cash & Equivalents is $2.2 million (2021), against an average of $2.2 million.
  • The sharpest move saw Cash & Equivalents tumbled 74.64% in 2022, then surged 765.67% in 2024.
  • Year by year, Cash & Equivalents stood at $2.2 million in 2021, then dropped by 29.43% to $1.5 million in 2022, then plummeted by 69.68% to $466000.0 in 2023, then surged by 765.67% to $4.0 million in 2024, then fell by 6.84% to $3.8 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $3.8 million, $4.0 million, and $3.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.